Major Pharmaceuticals recalls Levothyroxine Sodium Tablets
- Recalling company
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
- Reason
- Subpotent Drug
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 13, 2026
- Reported
- Jul 29, 2026
- Distribution
- Nationwide in the USA.
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026
- Company location
- Dublin, OH
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0702-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0702-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.